Articles Tagged With:
-
Combined TAVR and LAAO Studied in a Randomized Controlled Trial
In this randomized controlled trial of patients with atrial fibrillation undergoing transcatheter aortic valve replacement (TAVR), concomitant left atrial appendage occlusion at the time of TAVR was noninferior to TAVR plus medical therapy for a combined endpoint of death, stroke, and major bleeding at two years.
-
Another Hemodynamic Variant of Aortic Stenosis
A large, retrospective, observational study of patients with aortic valve gradients in the severe aortic stenosis range but with aortic valve areas in the moderate range has shown that such patients are not uncommon. Their prognosis is similar to patients with high-gradient severe aortic stenosis.
-
Clinical Features of Tachyarrhythmia-Induced Cardiomyopathy
A prospective observational study of patients with left ventricular dysfunction without known cause and tachyarrhythmias has shown that restoration of sinus rhythm significantly improves left ventricular function in more than 80% of such patients by six months and, initially, normal left ventricular size can be predictive of this response.
-
Prenatal Patient-Centered Contraceptive Counseling Is Important
New research suggests that pregnant patients who are interested in permanent contraception are offered information and counseling on this option late in their pregnancy, making it less likely they will access that option.
-
Adolescents Know More About Abortion Restrictions than Most Expect
Adolescents are fully aware and concerned about how abortion restrictions can affect them, and most use the internet and social media for information on abortion, new research shows.
-
Medication Abortion Through Telehealth Is Safe, Effective, and Convenient
Researchers began studying the safety and effectiveness of telehealth medication abortions in 2021 and concluded in 2022 before the U.S. Supreme Court decision to overturn Roe v. Wade. The recently published results showed that telehealth medication abortions are safe, with outcomes of 99.8% without serious adverse events.
-
OB/GYNs Experiencing High Levels of Moral Distress
An OB/GYN was asked by researchers how it felt to work in an abortion-ban state after the U.S. Supreme Court overturned Roe v. Wade — the physician’s response was shocking. The OB/GYN said working in a war zone with actual risk to one’s life was not as distressing as working with patients in an abortion-ban state where the physician continually feared arrest or patient death.
-
Telehealth Medication Abortion Remains Under Threat Even as Access Expands
In June, the U.S. Supreme Court is expected to decide the fate of the abortion medication mifepristone — a decision that could undermine access to the medication at a time when major pharmacies and retailers have begun to offer the pill. Abortion rights advocates, reproductive health clinicians, and others are bracing for a decision that could upend access to safe, legal self-managed abortions for most or all women in the nation.
-
Opill Rollout Includes Major Pharmacies and Retailers — but Price Tag Needs Work
The rollout of the nation’s first over-the-counter birth control pill, Opill, is a major step toward improving contraception access across the United States. But some obstacles remain, including cost and access for minors in places hostile to reproductive autonomy.
-
‘I Need My Brain!’: Horrors of Long COVID in HCWs
A systematic review of studies on healthcare workers who experienced long COVID in the United Kingdom revealed that many struggled to separate their clinical identity from that of a patient. Healthcare workers with various symptoms of long COVID endured over different lengths of time recognized the uncertainty of their symptoms of this poorly understood syndrome and feared they would be perceived as a burden.